Epigenetics in autoimmune diseases: Pathogenesis and prospects for therapy

Area of Science:

• Genetics and Molecular Biology
• Immunology

Background:

• Epigenetics involves heritable changes in genome function without altering DNA sequence.
• Epigenetic processes include DNA methylation, histone modification, non-coding RNA, and nucleosome remodeling.
• Dysregulation of these processes can impact chromosomal stability and gene expression, leading to complex syndromes.

Purpose of the Study:

• To explore the role of epigenetic alterations in human autoimmune diseases.
• To highlight the connection between epigenetic dysregulation and conditions such as SLE, RA, and MS.
• To underscore the potential of epigenetic studies in advancing autoimmune disease research.

Main Methods:

• Review of current literature on epigenetics and autoimmune diseases.
• Analysis of identified epigenetic alterations in systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS).
• Discussion of the implications of epigenetic dysregulation on disease mechanisms.

Main Results:

• Epigenetic alterations have been identified as contributors to major human autoimmune diseases.
• Specific epigenetic dysregulation provides new insights into the pathogenesis of SLE, RA, and MS.
• Emerging research highlights the link between epigenetic changes and autoimmune conditions.

Conclusions:

• Epigenetic studies offer novel perspectives on autoimmune diseases.
• Identification of specific epigenetic dysregulation can lead to the discovery of uncharacterized mechanisms.
• Further research into epigenetic alterations may yield valuable diagnostic biomarkers and therapeutic strategies for autoimmune diseases.